In humans, SIRT5 gene expression decreases in the liver of NAFLD patients (222), and the expression of SIRT5 in adipose tissue is positively correlated with insulin sensitivity (226). Here, SIRT5 is linked to metabolic dysfunction-associated steatotic liver disease.